Chapter 18. Recent Advances in the Design and Development of Antiobesity Agents
- 1 January 1980
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Suppression of food intake and body weight gain by naloxone in ratsLife Sciences, 1979
- Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by ratsLife Sciences, 1979
- Studies on fenfluramhe as an anti-obesity agentCurrent Medical Research and Opinion, 1979
- Effect of prolonged-action fenfluramine on weight and blood lipids in obese patienteCurrent Medical Research and Opinion, 1979
- Suppression of appetitive behavior in the rat by naloxone: Lack of effect of prior morphine dependenceLife Sciences, 1979
- Control of obesity inA vy /a mice by 5α-androstan-17-oneCellular and Molecular Life Sciences, 1978
- Body Weight: Reduction by Long-Term Glycerol TreatmentScience, 1977
- Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the ratLife Sciences, 1977
- Perfluorooctyl Bromide:A Potential Antiobesity CompoundJournal of Pharmaceutical Sciences, 1977
- Preliminary assessment of flutiorex, a new anorectic drug, in man.British Journal of Clinical Pharmacology, 1976